Literature DB >> 22783989

An analysis of C-reactive protein, procalcitonin, and D-dimer in pre-eclamptic patients.

Umran Kucukgoz Gulec1, Fatma Tuncay Ozgunen, Ahmet Baris Guzel, Selim Buyukkurt, Gulsah Seydaoglu, Ibrahim Ferhat Urunsak, Ismail Cuneyt Evruke.   

Abstract

PROBLEM: The aim of this study was to evaluate serum procalcitonin (PCT), C-reactive protein (CRP), and plasma D-Dimer levels in mild and severe pre-eclampsia. METHOD OF STUDY: Serum PCT, CRP, and D-Dimer levels were analyzed in 64 cases with pre-eclampsia as the study group and 33 healthy pregnant women in the third trimester as the control group. Pre-eclamptic group consisted of mild (n = 31) and severe pre-eclamptic subgroup (n = 33). Laboratory results were compared between the groups and diagnostic usefulness of these parameters were evaluated.
RESULTS: PCT, CRP, and D-Dimer levels were significantly higher in study group than the control group (P = 0.001). PCT, CRP, and D-Dimer were significantly higher in the patients with severe pre-eclampsia than mild pre-eclampsia. There were significant positive correlations between these markers and mean arterial pressure (MAP). Logistic regression analysis using the control and pre-eclampsia group showed that higher PCT (OR, 15.68; 95%-CI, 3.15-78.10), CRP (OR, 14.29; 95%-CI, 3.08-66.34), and D-Dimer levels (OR, 4.97; 95%-CI, 1.22-20.29) were found to be risk factors significantly associated with pre-eclampsia.
CONCLUSIONS: This study results confirm that evidence of a possible exaggerated systemic inflammatory response in pre-eclampsia especially in severe pre-eclampsia.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22783989     DOI: 10.1111/j.1600-0897.2012.01171.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  13 in total

Review 1.  Overview of procalcitonin in pregnancy and in pre-eclampsia.

Authors:  A Mangogna; C Agostinis; G Ricci; F Romano; R Bulla
Journal:  Clin Exp Immunol       Date:  2019-06-13       Impact factor: 4.330

2.  Maternal plasma soluble TRAIL is decreased in preeclampsia.

Authors:  Piya Chaemsaithong; Tinnakorn Chaiworapongsa; Roberto Romero; Steven J Korzeniewski; Tamara Stampalija; Nandor Gabor Than; Zhong Dong; Jezid Miranda; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2013-08-13

3.  Increased serum procalcitonin levels in pregnant patients with asymptomatic bacteriuria.

Authors:  Filiz Bilir; Nermin Akdemir; Selcuk Ozden; A Serhan Cevrioglu; Cemil Bilir
Journal:  Ann Clin Microbiol Antimicrob       Date:  2013-09-05       Impact factor: 3.944

Review 4.  A Dormant Microbial Component in the Development of Preeclampsia.

Authors:  Douglas B Kell; Louise C Kenny
Journal:  Front Med (Lausanne)       Date:  2016-11-29

Review 5.  Shared biomarkers between female diastolic heart failure and pre-eclampsia: a systematic review and meta-analysis.

Authors:  Lisa J Alma; Anouk Bokslag; Angela H E M Maas; Arie Franx; Walter J Paulus; Christianne J M de Groot
Journal:  ESC Heart Fail       Date:  2017-01-30

6.  Preeclampsia is a biomarker for vascular disease in both mother and child: the need for a medical alert system.

Authors:  Julie Hakim; Mary K Senterman; Antoine M Hakim
Journal:  Int J Pediatr       Date:  2013-04-16

7.  Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes.

Authors:  Henry Adekola; Roberto Romero; Piya Chaemsaithong; Steven J Korzeniewski; Zhong Dong; Lami Yeo; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2014-10-28

8.  Two variants of the C-reactive protein gene are associated with risk of pre-eclampsia in an American Indian population.

Authors:  Lyle G Best; Richa Saxena; Cindy M Anderson; Michael R Barnes; Hakon Hakonarson; Gilbert Falcon; Candelaria Martin; Berta Almoguera Castillo; Ananth Karumanchi; Kylie Keplin; Nichole Pearson; Felicia Lamb; Shellee Bercier; Brendan J Keating
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

9.  Complement activation and regulation in preeclamptic placenta.

Authors:  Anna Inkeri Lokki; Jenni Heikkinen-Eloranta; Hanna Jarva; Terhi Saisto; Marja-Liisa Lokki; Hannele Laivuori; Seppo Meri
Journal:  Front Immunol       Date:  2014-07-09       Impact factor: 7.561

10.  Level of High Sensitive C-reactive Protein and Procalcitonin in Pregnant Women with Mild and Severe Preeclampsia.

Authors:  Reihane Jannesari; Elham Kazemi
Journal:  Adv Biomed Res       Date:  2017-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.